Senior insider sale
LIGAND PHARMACEUTICALS INC — senior position signals high conviction
$754.4K
3.44K shares
What this filing means
KOZARICH JOHN W plans to sell 3.44K shares of LIGAND PHARMACEUTICALS INC valued at approximately $754.4K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 5/13/2026ACC: 0001950047-26-004441
3.44K
Shares to sell
$754.4K
Approx. market value
1.57K
Acquired (3 months)
1
Planned
4 completed
Securities Acquired — Last 3 Months1
Stock Option Exercise
Cash
5/13/2026
1.57KTotal acquired1.57K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
5/13/2026 | Stock Option Exercise Cash | 1.57K | — |
| Total | 1.57K | ||
Planned & Completed Dispositions5
Completed
—Completed
Units to sell
459.00
Market value
$102.8K
5/12/2026
—Completed
Units to sell
467.00
Market value
$111.5K
5/1/2026
—Completed
Units to sell
467.00
Market value
$94.4K
4/1/2026
—Completed
Units to sell
467.00
Market value
$93.6K
3/2/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
1.57K
Market value
$352.0K
5/13/2026
Total
Units
3.44K
Value
$754.4K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
5/12/2026 | 459.00 | $102.8K | — | Completed |
5/1/2026 | 467.00 | $111.5K | — | Completed |
4/1/2026 | 467.00 | $94.4K | — | Completed |
3/2/2026 | 467.00 | $93.6K | — | Completed |
| Planned — Approximate Date | ||||
5/13/2026 | 1.57K | $352.0K | NASDAQ | Planned |
| Total | 3.44K | $754.4K | ||